Skip to main content
Cellular and Molecular Life Sciences: CMLS logoLink to Cellular and Molecular Life Sciences: CMLS
. 1999 Jun;55(6-7):977–991. doi: 10.1007/s000180050348

Biological activity and pathological implications of misfolded proteins

V Bellotti 1, P Mangione 1, M Stoppini 1
PMCID: PMC11337856  PMID: 10412375

Abstract.

The physiological metabolism of proteins guarantees that different cellular compartments contain the appropriate concentration of proteins to perform their biological functions and, after a variable period of wear and tear, mediates their natural catabolism. The equilibrium between protein synthesis and catabolism ensures an effective turnover, but hereditary or acquired abnormalities of protein structure can provoke a premature loss of biological function, an accelerated catabolism and diseases caused by the loss of an irreplaceable function. In certain proteins, abnormal structure and metabolism are associated with a strong tendency to self-aggregation into a polymeric fibrillar structure, and in these cases the disease is not principally caused by the loss of an irreplaceable function but by the action of this new biological entity. Amyloid fibrils are an apparently inert, insoluble, mainly extracellular protein polymer that kills the cell without tissue necrosis but by activation of the apoptotic mechanism. We analyzed the data reported so far on the structural and functional properties of four prototypic proteins with well-known biological functions (lysozyme, transthyretin, β2-microglobulin and apolipoprotein AI) that are able to create amyloid fibrils under certain conditions, with the perspective of evaluating whether the achievement of biological function favors or inhibits the process of fibril formation. Furthermore, studying the biological functions carried out by amyloid fibrils reveals new types of protein-protein interactions in the transmission of messages to cells and may provide new ideas for effective therapeutic strategies.

Keywords: Key words. Amyloidosis; protein misfolding; lysozyme; β2-microglobulin; apolipoprotein AI; transthyretin; β protein.

Footnotes

Received 9 November 1998; received after revision 15 January 1999; accepted 15 January 1999


Articles from Cellular and Molecular Life Sciences: CMLS are provided here courtesy of Springer

RESOURCES